Sign in
Taking peoplePhase 3

Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults

Key facts

Who runs it
London School of Hygiene and Tropical Medicine
Where
United Kingdom2 sites in 1 countryChoose a country to see its sites
Status
Recruiting
Phase
Phase 3
People taking part
5,000 people, planned
Started
18 Apr 2021
Expected to end
31 Jan 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Tranexamic Acid 500 MG
Record updated
12 March 2026

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • 50 years or older (actual or estimated)
  • History or evidence of head injury (e.g. laceration, bruise, swelling or pain in head or face)
  • GCS ≥ 13
  • Has one or more of the following:; has or had any impaired consciousness (loss of consciousness, amnesia, or confusion); nausea or vomiting
  • Within 3 hours of injury (do not include if interval cannot be estimated e.g. patient unable to confirm time of fall or patient found on floor after an unwitnessed fall and home alone)
  • Not living in a nursing home, mental health institution or prison
  • Patient will be conveyed to or is admitted to a participating hospital

Who cannot take part

  • TXA not clearly indicated (e.g. major bleeding) or contraindicated (e.g. suspected stroke)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Tranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and dementia in older adults with symptomatic mild head injury

The 2 groups in the trial

  • ActiveExisting treatment, for comparison

    A single dose of Tranexamic acid 500mg given by intramuscular injection

    Treatment: Tranexamic Acid 500 MG

  • PlaceboPlacebo, for comparison

    One Injection of the placebo which is 10 mL Sodium Chloride (0.9%)

    Treatment: Tranexamic Acid 500 MG

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Intramuscular Tranexamic Acid for the Treatment of Symptomatic Mild Traumatic Brain Injury in Older Adults: a Randomised, Double-blind, Placebo-controlled Trial
Record updated
12 March 2026